Company intelligence / Profile preview

Cannara Biotech

Saint-Laurent, Quebec, Canadacannara.ca ↗

Ownership: Private
Development stage: Other

Overview

Cannara Biotech operates two large-scale indoor cultivation facilities in Quebec with a combined capacity exceeding 100,000 kg annually. The company has achieved record revenue growth and profitability in recent quarters by expanding its national market share through premium brands. It continues to innovate with new genetic releases and expanded distribution across Canada.[3][7][9] No clinical trial results are reported as the business focuses on commercial production rather than drug development.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculePlant-derived therapy
Industry: Agriculture & AgTech

Partnerships

Exotic Genetix

Beyond the preview

Go deeper on Cannara Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cannara Biotech.

Explore the full profile